Health ministry to amend Rule 96 of D&C Rules to streamline labeling requirements of iron tablets and polio drops

The Union health ministry will soon amend Rule 96 of the Drugs and Cosmetics (D&C) Rules to streamline labeling requirements of iron tablets and polio drops to provide requisite information to the consumer.

The proposal to amend Rule 96 of the D&C Rules, 1945 for labeling of iron tablets and polio drops distributed to the children under government programmes with name and expiry date in Hindi also was deliberated at the Drug Technical Advisory Board (DTAB)'s 78th meeting.

In order to do the same, the ministry had constituted a sub-committee under the chairmanship of Indian Medical Association (IMA) Secretary General Dr RN Tandon to examine and give recommendations for streamlining the labeling requirements of drugs.

The sub-committee members and co-opted experts, as per the terms of references, examined the feasibility of printing the name of medicine and expiry date in Hindi on label of the drug products and submitted the minutes of meetings along with recommendations.

The sub-committee in its recommendations concluded that while name of medicines shall be printed both in English and Hindi for open market, medicines procured by any Government agency are at liberty to ask for regional language on label of drug products along with English.

DTAB deliberated on the recommendation of the sub-committee and suggested that government procurement agencies take necessary steps in tendering process to include drug name and expiry date in Hindi or regional language along with English on the label of iron tablets and polio drops in Government programmes in addition to the existing conditions of Rule 96 of D&C Rules. It was further recommended that an advisory may be issued by Government in this regard.

DTAB also recommended that the sub-committee may co-opt the representatives from pharmaceutical manufacturing industry and Indian pharmaceutical association for further deliberations on the overall issues related to labeling requirements of drugs.


Comments

Popular posts from this blog

China-India joint summit discusses bilateral trade to improve pharma industry

Webinar on ‘OPPORTUNITY TO COMMERCIALIZE HERBAL RESEARCH’